Lv2
198 积分 2023-06-14 加入
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial
12天前
已完结
Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung Cancer
12天前
已完结
Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY
12天前
已完结
Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development
12天前
已完结
Rethinking the role of synergy calculations in the next century of drug combination discovery
17天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
17天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
19天前
已完结
Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
22天前
已完结
Dual Physiological Barriers Bypassed by a Silk‐Based Supramolecular Protein Delivery Platform for Neuroinflammation Mitigation in Alzheimer's Disease
27天前
已完结
Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson's disease
1个月前
已完结
皖公网安备34019202002308
